RecruitingNCT07443618

Measuring Fluid Buildup in Cancer Patients

Monitoring of Oedema in Cancer Patients - A Pilot Study


Sponsor

Jens Rikardt Andersen

Enrollment

46 participants

Start Date

Feb 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to improve the monitoring of fluid retention in cancer patients. The main question it aims to answer is: Can segmental bioelectrical impedance analysis be used to monitor local fluid retention (edema) in cancer patients? We will include: * Breast cancer patients with fluid and or lymph retention in one or both arms after radiotherapy (outpatients) * Cancer patients with fluid retention in one or both legs after chemotherapy (hospitalized) Participants will: * Have measurements taken using bioelectrical impedance * Provide blood samples and 24-hour urine collection * Weight monitorering * Complete diet and fluid registration (inclusive enteral and parenteral) * Have clinical palpatory and measurement assessment of oedema.


Eligibility

Min Age: 18 Years

Inclusion Criteria13

  • Habile
  • Must be able to speak and read Danish
  • Has received/is receiving radiotherapy due to breast cancer within the last 6 months
  • Is being followed in the Oncology Outpatient Clinic at Aalborg University Hospital
  • Age ≥ 18 years
  • Visible lymphoedema in at least one upper extremity
  • Habile
  • Must be able to speak and read Danish
  • Has received/is receiving chemotherapy due to cancer within the last 2 months
  • Hospitalised in the Oncology Ward at Aalborg University Hospital
  • Estimated length of hospital stay of at least 6 days
  • Age ≥ 18 years
  • Visible peripheral oedema in at least one lower extremity

Exclusion Criteria9

  • Pregnant or breastfeeding women
  • Amputated limb(s)
  • Pacemaker or implanted cardioverter-defibrillator due to risk of interference from the electrical signal
  • Metallic prostheses due to risk of interference with the device signal
  • Inability to lie still for the duration of the measurement interval (minimum 2 minutes at a time)
  • Inability to stand on a scale, i.e. permanently bedridden.
  • Inability to cooperate with urine collection
  • Receiving dialysis
  • Terminal illness

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Aalborg University Hospital

Aalborg, The North Denmark Region, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07443618


Related Trials